Angiomyolipoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angiomyolipoma}} | {{Angiomyolipoma}} | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Faizan}},{{Rekha}} | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of angiomyolipoma include presence of [[red blood cell]]s in urine/ CRF due to replacement and compression of renal parenchyma and elevated white blood cell count. | Laboratory findings consistent with the diagnosis of angiomyolipoma include presence of [[red blood cell]]s in urine/ CRF due to replacement and compression of renal parenchyma and elevated white blood cell count. | ||
Revision as of 11:49, 11 September 2018
|
Angiomyolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Angiomyolipoma laboratory findings On the Web |
|
American Roentgen Ray Society Images of Angiomyolipoma laboratory findings |
|
Risk calculators and risk factors for Angiomyolipoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2],Rekha, M.D.
Overview
Laboratory findings consistent with the diagnosis of angiomyolipoma include presence of red blood cells in urine/ CRF due to replacement and compression of renal parenchyma and elevated white blood cell count.
Laboratory Findings
Laboratory findings consistent with the diagnosis of angiomyolipoma include:[1]
| Laboratory test | Concentrations |
|---|---|
| |
| |
|
References
- ↑ Eijkemans MJ, van der Wal W, Reijnders LJ, Roes KC, van Waalwijk van Doorn-Khosrovani SB, Pelletier C; et al. (2015). "Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands". Am J Kidney Dis. 66 (4): 638–45. doi:10.1053/j.ajkd.2015.05.016. PMID 26165440.